Fig. 3.
Fig. 3. Time to CMV antigenemia clearance. / All patients who developed CMV antigenemia during the first 100 days after transplantation and who received ganciclovir induction and maintenance therapy are displayed. For weekly intervals, the percentages of CMV Ag-positive patients are shown following the first positive CMV Ag test (diagnosis). The denominators are all patients initially CMV Ag-positive.

Time to CMV antigenemia clearance.

All patients who developed CMV antigenemia during the first 100 days after transplantation and who received ganciclovir induction and maintenance therapy are displayed. For weekly intervals, the percentages of CMV Ag-positive patients are shown following the first positive CMV Ag test (diagnosis). The denominators are all patients initially CMV Ag-positive.

Close Modal

or Create an Account

Close Modal
Close Modal